These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 8586467

  • 1. Molecular pathways in the formation of gliomas.
    von Deimling A, Louis DN, Wiestler OD.
    Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
    [Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. [Towards a molecular classification of gliomas].
    Hoang-Xuan K, Idbaih A, Mokhtari K, Sanson M.
    Bull Cancer; 2005 Apr 01; 92(4):310-6. PubMed ID: 15888387
    [Abstract] [Full Text] [Related]

  • 4. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Apr 01; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [OMICS and biomarkers of glial tumors].
    Idbaih A.
    Rev Neurol (Paris); 2011 Oct 01; 167(10):691-8. PubMed ID: 21889780
    [Abstract] [Full Text] [Related]

  • 8. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nistér M, Smits A, Ren ZP.
    Acta Neuropathol; 2007 Feb 01; 113(2):129-36. PubMed ID: 17031656
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH, Kim JH, Rhee CH, Kang YS, Lee JH, Hong SI, Choi KS.
    J Korean Med Sci; 1995 Dec 01; 10(6):442-8. PubMed ID: 8924230
    [Abstract] [Full Text] [Related]

  • 16. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW, Broholm H, Laursen H.
    Ugeskr Laeger; 2006 Oct 30; 168(44):3813-6. PubMed ID: 17118240
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.